Literature DB >> 6840809

IgE and IgD antibodies to cow milk and soy protein in duodenal fluid: effects of pancreozymin and secretin.

S Freier, E Lebenthal, M Freier, P C Shah, B H Park, P C Lee.   

Abstract

Duodenal fluid IgE was reported to be increased in food allergy and in inflammatory conditions of the bowel. We studied the presence and specificity of IgE and IgD antibodies against alpha-casein, beta-lactoglobulin A, alpha-lactalbumin, bovine serum albumin and soy bean agglutinin using an enzyme-linked immunoassay (ELISA). Thirteen children with various intestinal diseases and thirteen normal adult volunteers were examined. In resting duodenal fluids, 8/13 of the children had IgE and 5/13 had IgD, while only 1/13 of the adults showed detectable IgE and IgD. After pancreozymin, 4/6 of the children and 4/8 of the adults showed detectable IgE and IgD in their duodenal fluids. After secretin, the duodenal fluids from 1/8 of the children and 2/8 of the adults had detectable IgE, while 6/13 children and 1/10 of the adults had IgD. The results indicate an increase in duodenal contents of IgE and IgD antibodies specific to cow's milk and soy protein after pancreozymin. Since this mediator is normally released during digestion, it is suggested that IgE and IgD antibodies specific for food proteins, may be involved in the physiological processing of foods in the intestine. In infants and children with gastrointestinal disease, the incidence of IgE and IgD antibodies specific for milk and soy proteins is higher in basal and pancreozymin-stimulated duodenal fluid when compared with control adults.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840809      PMCID: PMC1454106     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Human secretory component--VI. Immunoglobulin-binding properities.

Authors:  P Brandtzaeg
Journal:  Immunochemistry       Date:  1977-03

Review 2.  Secretin.

Authors:  W H Häcki
Journal:  Clin Gastroenterol       Date:  1980-09

3.  Inconclusive immunohistochemistry of human IgE in mucosal pathology.

Authors:  P Brandtzaeg; K Baklien
Journal:  Lancet       Date:  1976-06-12       Impact factor: 79.321

4.  Immunoglobulin-containing cells in the intestinal mucosa and immunoglobulins in the intestinal juice in children.

Authors:  E Savilahti
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

5.  Immunoglobulin characterization of human pancreatic fluid.

Authors:  G W Brasher; W P Dyck; F F Hall; A M Spiekerman
Journal:  Am J Dig Dis       Date:  1975-05

6.  Immunoglobulin concentrations in the duodenal fluids of infants and children. II. The effect of pancreozymin and secretin.

Authors:  E Lebenthal; B Clark
Journal:  Am J Gastroenterol       Date:  1981-06       Impact factor: 10.864

7.  IgE levels in intestinal juice.

Authors:  D Belut; D A Moneret-Vautrin; J P Nicolas; J P Grilliat
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

8.  Immunoglobulin concentrations in duodenal fluid of infants and children.

Authors:  E Lebenthal; B A Clark; O Kim
Journal:  Am J Dis Child       Date:  1980-09

9.  Extent and duration of small intestinal mucosal injury in intractable diarrhea of infancy.

Authors:  T M Rossi; E Lebenthal; K S Nord; R R Fazili
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

10.  Origin and fate of IgE-bearing lymphocytes. I. Peyer's patches as differentiation site of cells. Simultaneously bearing IgA and IgE.

Authors:  H G Durkin; H Bazin; B H Waksman
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Mucosal antibodies in the regulation of tolerance and allergy to foods.

Authors:  M Cecilia Berin
Journal:  Semin Immunopathol       Date:  2012-07-10       Impact factor: 9.623

2.  Evidence for an interleukin 4-inducible immunoglobulin E uptake and transport mechanism in the intestine.

Authors:  K Ramaswamy; J Hakimi; R G Bell
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.